Psychiatric Genetics最新文献

{"title":"Analysis of convergence of linkage and association studies in autism spectrum disorders.","authors":"Ioanna Mpoulimari,&nbsp;Elias Zintzaras","doi":"10.1097/YPG.0000000000000341","DOIUrl":"10.1097/YPG.0000000000000341","url":null,"abstract":"<p><p>Autism spectrum disorder (ASD) is a clinically and genetically heterogeneous group of pervasive neurodevelopmental disorders with a strong hereditary component. Although genome-wide linkage studies (GWLS) and [genome-wide association studies (GWAS)] have previously identified hundreds of ASD risk gene loci, the results remain inconclusive. In this study, a genomic convergence approach of GWAS and GWLS for ASD was implemented for the first time in order to identify genomic loci supported by both methods. A database with 32 GWLS and five GWAS for ASD was created. Convergence was quantified as the proportion of significant GWAS markers located within linked regions. Convergence was not found to be significantly higher than expected by chance (z-test = 1,177, P = 0,239). Although convergence is supportive of genuine effects, the lack of agreement between GWLS and GWAS is also indicative that these studies are designed to answer different questions and are not equally well suited for deciphering the genetics of complex traits.</p>","PeriodicalId":20734,"journal":{"name":"Psychiatric Genetics","volume":"33 3","pages":"113-124"},"PeriodicalIF":0.9,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9630965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Emotional dysregulation, alexithymia and neuroticism: a systematic review on the genetic basis of a subset of psychological traits.","authors":"Giovanni Castellini, Giuseppe Pierpaolo Merola, Ottone Baccaredda Boy, Vincenzo Pecoraro, Bernardo Bozza, Emanuele Cassioli, Eleonora Rossi, Valentina Bessi, Sandro Sorbi, Benedetta Nacmias, Valdo Ricca","doi":"10.1097/YPG.0000000000000335","DOIUrl":"10.1097/YPG.0000000000000335","url":null,"abstract":"<p><p>Neuroticism, alexithymia and emotion dysregulation are key traits and known risk factors for several psychiatric conditions. In this systematic review, the aim is to evaluate the genetic contribution to these psychological phenotypes. A systematic review of articles found in PubMed was conducted. Search terms included 'genetic', 'GWAS', 'neuroticism', 'alexithymia' and 'emotion dysregulation'. Risk of bias was assessed utilizing the STREGA checklist. Two hundred two papers were selected from existing literature based on the inclusion and exclusion criteria. Among these, 27 were genome-wide studies and 175 were genetic association studies. Single gene association studies focused on selected groups of genes, mostly involved in neurotransmission, with conflicting results. GWAS studies on neuroticism, on the other hand, found several relevant and replicated intergenic and intronic loci affecting the expression and regulation of crucial and well-known genes (such as DRD2 and CRHR1). Mutations in genes coding for trascriptional factors were also found to be associated with neuroticism (DCC, XKR6, TCF4, RBFOX1), as well as a noncoding regulatory RNA (LINC00461). On the other hand, little GWAS data are available on alexythima and emotional dysregulation.</p>","PeriodicalId":20734,"journal":{"name":"Psychiatric Genetics","volume":"33 3","pages":"79-101"},"PeriodicalIF":1.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9682565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gene and schizophrenia in the pregenome and postgenome-wide association studies era: a bibliometric analysis and network visualization.","authors":"Wan Nur Amalina Zakaria,&nbsp;Teguh Haryo Sasongko,&nbsp;Badryia Al-Rahbi,&nbsp;Noorah Al-Sowayan,&nbsp;Asma Hayati Ahmad,&nbsp;Rahimah Zakaria,&nbsp;Aidi Ahmi,&nbsp;Zahiruddin Othman","doi":"10.1097/YPG.0000000000000336","DOIUrl":"10.1097/YPG.0000000000000336","url":null,"abstract":"<p><p>This study aimed to perform a bibliometric analysis on genetic studies in schizophrenia in the pregenome-wide association studies (GWAS) and post-GWAS era. We searched the literature on genes and schizophrenia using the Scopus database. The documents increased with time, especially after the human genome project and International HapMap Project, with the highest citation in 2008. The top occurrence author keywords were discovered to be different in the pre-GWAS and post-GWAS eras, reflecting the progress of genetic studies connected to schizophrenia. Emerging keywords highlighted a trend towards an application of precision medicine, showing an interplay of environmental exposures as well as genetic factors in schizophrenia pathogenesis, progression, and response to therapy. In conclusion, the gene and schizophrenia literature has grown rapidly after the human genome project, and the temporal variation in the author keywords pattern reflects the trend of genetic studies related to schizophrenia in the pre-GWAS and post-GWAS era.</p>","PeriodicalId":20734,"journal":{"name":"Psychiatric Genetics","volume":"33 2","pages":"37-49"},"PeriodicalIF":0.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9411993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Study protocol of DIVERGE, the first genetic epidemiological study of major depressive disorder in Pakistan.","authors":"Maria Valkovskaya,&nbsp;Arsalan Hassan,&nbsp;Eirini Zartaloudi,&nbsp;Fahad Hussain,&nbsp;Muhammad Umar,&nbsp;Bakht Khizar,&nbsp;Inzemam Khattak,&nbsp;Shamshad Ahmed Gill,&nbsp;Shams-Ud-Din Ahmad Khan,&nbsp;Imtiaz Ahmad Dogar,&nbsp;Ali Burhan Mustafa,&nbsp;Moin Ahmed Ansari,&nbsp;Syed Qalb I Hyder,&nbsp;Muhammad Ali,&nbsp;Nilofar Ilyas,&nbsp;Parveen Channar,&nbsp;Nazish Mughal,&nbsp;Sumera Channa,&nbsp;Khalid Mufti,&nbsp;Ali Ahsan Mufti,&nbsp;Mian Iftikhar Hussain,&nbsp;Sadia Shafiq,&nbsp;Muhammad Tariq,&nbsp;Muhammad Kamran Khan,&nbsp;Shahzad Tahir Chaudhry,&nbsp;Abdul Rashid Choudhary,&nbsp;Mian Nizam Ali,&nbsp;Gohar Ali,&nbsp;Ashfaq Hussain,&nbsp;Muhammad Rehman,&nbsp;Noman Ahmad,&nbsp;Saeed Farooq,&nbsp;Farooq Naeem,&nbsp;Tanveer Nasr,&nbsp;Glyn Lewis,&nbsp;James A Knowles,&nbsp;Muhammad Ayub,&nbsp;Karoline Kuchenbaecker","doi":"10.1097/YPG.0000000000000333","DOIUrl":"10.1097/YPG.0000000000000333","url":null,"abstract":"<p><strong>Introduction: </strong>Globally, 80% of the burdenof major depressive disorder (MDD) pertains to low- and middle-income countries. Research into genetic and environmental risk factors has the potential to uncover disease mechanisms that may contribute to better diagnosis and treatment of mental illness, yet has so far been largely limited to participants with European ancestry from high-income countries. The DIVERGE study was established to help overcome this gap and investigate genetic and environmental risk factors for MDD in Pakistan.</p><p><strong>Methods: </strong>DIVERGE aims to enrol 9000 cases and 4000 controls in hospitals across the country. Here, we provide the rationale for DIVERGE, describe the study protocol and characterise the sample using data from the first 500 cases. Exploratory data analysis is performed to describe demographics, socioeconomic status, environmental risk factors, family history of mental illness and psychopathology.</p><p><strong>Results and discussion: </strong>Many participants had severe depression with 74% of patients who experienced multiple depressive episodes. It was a common practice to seek help for mental health struggles from faith healers and religious leaders. Socioeconomic variables reflected the local context with a large proportion of women not having access to any education and the majority of participants reporting no savings.</p><p><strong>Conclusion: </strong>DIVERGE is a carefully designed case-control study of MDD in Pakistan that captures diverse risk factors. As the largest genetic study in Pakistan, DIVERGE helps address the severe underrepresentation of people from South Asian countries in genetic as well as psychiatric research.</p>","PeriodicalId":20734,"journal":{"name":"Psychiatric Genetics","volume":"33 2","pages":"69-78"},"PeriodicalIF":0.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997631/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9359855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pathoclinical associations between panic disorders and the brain-derived neurotrophic factor Val66Met polymorphism: an updated meta-analysis.","authors":"Yu Xia,&nbsp;Xun Song,&nbsp;Lijuan Wu,&nbsp;Jun Li,&nbsp;Nan Liu,&nbsp;Wenhui Cui","doi":"10.1097/YPG.0000000000000337","DOIUrl":"10.1097/YPG.0000000000000337","url":null,"abstract":"<p><p>Prior studies have indicated the pathological role of brain-derived neurotrophic factor (BDNF) gene polymorphism in panic disorders (PD). A functionally less active BDNF Val66Met mutant was previously detected in PD patients with different ethnic backgrounds. However, the results remain inconclusive or inconsistent. A meta-analysis was used to explore the consistency of the BDNF Val66Met mutant's association with PD irrespective of the subject's ethnicity. Relevant case-controlled full-length clinical and preclinical reports were retrieved by database searching, and 11 articles involving 2203 cases and 2554 controls were systematically selected per the standard inclusion criteria. Eleven articles were finally included that explored the relationship between the Val66Met polymorphism and PD risk susceptibility. Statistical analysis revealed a significant genetic association of the mutation, allele frequencies, and genotype distributions of BDNF with PD onset. Our findings demonstrated that the BDNF Val66Met is a susceptibility factor of PD.</p>","PeriodicalId":20734,"journal":{"name":"Psychiatric Genetics","volume":"33 2","pages":"50-58"},"PeriodicalIF":0.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ca/64/pg-33-50.PMC9997625.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9709581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating the genetic interaction effects of gut microbiome and diet on the risk of neuroticism in the UK Biobank cohort.","authors":"Dan He,&nbsp;Xi Wang,&nbsp;Jing Ye,&nbsp;Yao Yao,&nbsp;Yan Wen,&nbsp;Yumeng Jia,&nbsp;Peilin Meng,&nbsp;Xuena Yang,&nbsp;Cuiyan Wu,&nbsp;Yujie Ning,&nbsp;Sen Wang,&nbsp;Feng Zhang","doi":"10.1097/YPG.0000000000000334","DOIUrl":"10.1097/YPG.0000000000000334","url":null,"abstract":"<p><strong>Objectives: </strong>In this study designed to investigate the effect of diet and gut microbiome on neuropsychiatric disorders, we explored the mechanisms of the interaction between diet and gut microbiome on the risk of neuroticism.</p><p><strong>Methods: </strong>First, using the individual genotype data from the UK Biobank cohort (N = 306 165), we calculated the polygenic risk score (PRS) based on 814 dietary habits single nucleotide polymorphisms (SNPs), 21 diet compositions SNPs and 1001 gut microbiome SNPs, respectively. Gut microbiome and diet-associated SNPs were collected from three genome-wide association studies (GWAS), including the gut microbiome (N = 3890), diet compositions (over 235 000 subjects) and dietary habits (N = 449 210). The neuroticism score was calculated by 12 questions from the Eysenck Personality Inventory Neuroticism scale. Then, regression analysis was performed to evaluate the interaction effects between diet and the gut microbiome on the risk of neuroticism.</p><p><strong>Results: </strong>Our studies demonstrated multiple candidate interactions between diet and gut microbiome, such as protein vs. Bifidobacterium (β = 4.59 × 10-3; P = 9.45 × 10-3) and fat vs. Clostridia (β = 3.67 × 10-3; P = 3.90 × 10-2). In addition, pieces of fresh fruit per day vs. Ruminococcus (β = -5.79 × 10-3, P = 1.10 × 10-3) and pieces of dried fruit per day vs. Clostridiales (β = -5.63 × 10-3, P = 1.49 × 10-3) were found to be negatively associated with neuroticism in fruit types. We also identified several positive interactions, such as tablespoons of raw vegetables per day vs. Veillonella (β = 5.92 × 10-3, P = 9.21 × 10-4) and cooked vegetables per day vs. Acidaminococcaceae (β = 5.69 × 10-3, P = 1.24 × 10-3).</p><p><strong>Conclusions: </strong>Our results provide novel clues for understanding the roles of diet and gut microbiome in the development of neuroticism.</p>","PeriodicalId":20734,"journal":{"name":"Psychiatric Genetics","volume":"33 2","pages":"59-68"},"PeriodicalIF":0.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9710090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Psychosis and autism without functional regression in a patient with Kleefstra syndrome.","authors":"Mark A Colijn,&nbsp;Cherelyn M Lakusta,&nbsp;Julien L Marcadier","doi":"10.1097/YPG.0000000000000330","DOIUrl":"https://doi.org/10.1097/YPG.0000000000000330","url":null,"abstract":"<p><p>Kleefstra syndrome is a rare genetic disorder caused by haploinsufficiency of the euchromatic histone lysine methyltransferase 1 (EHMT1) gene. It is characterized by a variety of dysmorphic features, comorbid medical issues, and developmental delays/intellectual disability. Neuropsychiatric symptoms may also occur, including autistic features and psychosis, and are often accompanied by functional regression. However, the phenomenology of psychotic symptoms in this syndrome has not been well described in the literature. As such, in this brief report, we review the literature with respect to the occurrence of psychosis in Kleefstra syndrome and describe the symptom profile of a 35-year-old affected male with an intellectual disability, autism spectrum disorder, and schizophrenia (in association with manic features). This is the first report of psychotic symptoms fully remitting in response to zuclopenthixol therapy in an individual with Kleefstra syndrome. This case is also unique as it demonstrates that functional regression does not necessarily coincide with the development of schizophrenia-like presentations in affected individuals.</p>","PeriodicalId":20734,"journal":{"name":"Psychiatric Genetics","volume":"33 1","pages":"34-36"},"PeriodicalIF":0.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10789258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identification of rare missense mutations in the glutamate ionotropic receptor AMPA type subunit genes in schizophrenia.","authors":"Ko-Huan Lin,&nbsp;Tsung-Ming Hu,&nbsp;Shih-Hsin Hsu,&nbsp;Hsin-Yao Tsai,&nbsp;Min-Chih Cheng","doi":"10.1097/YPG.0000000000000328","DOIUrl":"https://doi.org/10.1097/YPG.0000000000000328","url":null,"abstract":"<p><strong>Objective: </strong>The alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors significantly regulate the synaptic transmission and functions of various synaptic receptors. This study aimed to identify single nucleotide mutations in the glutamate receptor, ionotropic, AMPA type (GRIA) gene family, which is associated with schizophrenia.</p><p><strong>Methods: </strong>The exon regions of four genes (GRIA1, GRIA2, GRIA3, and GRIA4) encoding glutamate ionotropic receptor AMPA type proteins were resequenced in 516 patients with schizophrenia. We analyzed the protein function of the identified rare mutants via immunoblotting.</p><p><strong>Results: </strong>A total of 24 coding variants were detected in the GRIA gene family, including six missense mutations, 17 synonymous mutations, and one frameshift insertion. Notably, three ultra-rare missense mutations (GRIA1p.V182A, GRIA2p.P123Q, and GRIA4p.Y491H) were not documented in the single nucleotide polymorphism database, gnomAD genomes, and 1517 healthy controls available from Taiwan BioBank. Immunoblotting revealed GRIA4p.Y491H mutant with altered protein expressions in cultured cells compared with the wild type.</p><p><strong>Conclusion: </strong>Our findings suggest that, in some patients affected by schizophrenia, the GRIA gene family harbors rare functional mutations, which support rare coding variants that could contribute to the genetic architecture of this illness. The in-vitro impacts of these rare pathological mutations on the pathophysiology of schizophrenia are worthy of future investigation.</p>","PeriodicalId":20734,"journal":{"name":"Psychiatric Genetics","volume":"33 1","pages":"20-25"},"PeriodicalIF":0.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10789259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Investigation of the forkhead box protein P2 gene by the next-generation sequence analysis method in children diagnosed with specific learning disorder.","authors":"Merve Yazıcı,&nbsp;Çiğdem Yektaş,&nbsp;Recep Eröz,&nbsp;Elif Sümeyra Kaplan Karakaya,&nbsp;Enes Sarıgedik","doi":"10.1097/YPG.0000000000000326","DOIUrl":"https://doi.org/10.1097/YPG.0000000000000326","url":null,"abstract":"<p><strong>Objective: </strong>It was aimed to investigate the role of the forkhead box protein P2 (FOXP2) gene in the cause of specific learning disorder (SLD) with the next-generation sequencing method.</p><p><strong>Material and methods: </strong>The study included 52 children diagnosed with SLD and 46 children as control between the ages of 6-12 years. Interview Schedule for Affective Disorders and Schizophrenia for School-Age Children, Present and Lifelong Version in Turkish, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)-Based Screening and Evaluation Scale for Attention Deficit and Disruptive Behavior Disorders, Specific Learning Disability Test Battery were applied to all participants. The FOXP2 gene was screened by the next-generation sequencing (NGS) method in all participants.</p><p><strong>Results: </strong>A total of 17 variations were detected in the FOXP2 gene in participants. The number and diversity of variations were higher in the patient group. In the patient group, c.1914 + 8A>T heterozygous variation and three different types of heterozygous variation (13insT, 13delT and 4dup) in the c.1770 region were detected. It was found that the detected variations showed significant relationships with the reading phenotypes determined by the test battery.</p><p><strong>Conclusion: </strong>It was found that FOXP2 variations were seen more frequently in the patient group. Some of the detected variations might be related to the clinical phenotype of SLD and variations found in previous studies from different countries were not seen in Turkish population. Our study is the first to evaluate the role of FOXP2 gene variations in children with SLD in Turkish population, and novel variations in the related gene were detected.</p>","PeriodicalId":20734,"journal":{"name":"Psychiatric Genetics","volume":"33 1","pages":"8-19"},"PeriodicalIF":0.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10789255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Genetics of nonpharmacological treatments of depression.","authors":"Raffaella Zanardi,&nbsp;Matteo Carminati,&nbsp;Francesco Attanasio,&nbsp;Chiara Fabbri,&nbsp;Alessandro Serretti","doi":"10.1097/YPG.0000000000000332","DOIUrl":"https://doi.org/10.1097/YPG.0000000000000332","url":null,"abstract":"<p><p>Nonpharmacological antidepressant treatments are effective and well tolerated in selected patients. However, response is heterogeneous and validated biomarkers would be precious to aid treatment choice. We searched Pubmed, Scopus, and Google Scholar until May 2022 for original articles evaluating the association of genetic variables with the efficacy of nonpharmacological treatments for major depressive episodes. Most studies analyzed small sample sizes using the candidate gene approach, leading to poorly replicated findings that need to be interpreted cautiously. The few available methylome-wide and genome-wide association studies (GWASs) considered only electroconvulsive therapy (ECT) and cognitive-behavioral therapy in small samples, providing interesting findings by using polygenic risk scores. A deeper knowledge of the genetic factors implicated in treatment response may lead to a better understanding of the neurobiological mechanisms of nonpharmacological therapies for depression, and depression itself. Future GWAS are going to expand their sample size, thanks to consortia such as the gen-ECT-ic consortium.</p>","PeriodicalId":20734,"journal":{"name":"Psychiatric Genetics","volume":"33 1","pages":"1-7"},"PeriodicalIF":0.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10789257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}